CAO Morales Mallory bought 300 IMRX shares at $6.39; prior buys at this ticker lost -29.3% and -33.8% in 30 days
Morales Mallory, Chief Accounting Officer, purchased 300 shares of Immuneering Corp on 2025-10-01 at $6.39, adding to holdings of 27.5K shares. This represents a small incremental position increase of 1.1%. However, the timing is concerning: his two prior open-market purchases at IMRX in March 2024 declined -29.3% and -33.8% over the following 30 days, with neither well-timed at the 90-day mark. Additionally, his broader cross-ticker track record shows 2 prior buys with an average 30-day return of -31.5% and a 0.00% win rate over 90 days. The company itself faces headwinds, with zero revenue in the latest quarter and a net loss of $-14,433,881.00, along with -100.0% annual revenue growth. While 3 other insiders also bought within the past 14 days (a cluster pattern), the CAO's personal history of ill-timed purchases and the company's financial distress suggest this transaction warrants cautious scrutiny of underlying motivations and fundamentals.